Etiology of intestinal metaplasia at the gastroesophageal junction: Reflux, H. pylori infection, or both?

Surgical Endoscopy and Other Interventional Techniques

Volumn 17, Issue 1, 2003, Pages 43-48

  Balaji, N S ^a   DeMeester, S R ^a   Wickramasinghe, K S ^a   Hagen, J A ^a   Peters, J H ^a   DeMeester, T R ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; INTERMEDIATE FILAMENT PROTEIN; KERATIN; KRT20 PROTEIN, HUMAN; KRT7 PROTEIN, HUMAN;

ARTICLE; BARRETT ESOPHAGUS; CLINICAL ARTICLE; CONTROLLED STUDY; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; LOWER ESOPHAGUS SPHINCTER; PATHOGENESIS; PRIORITY JOURNAL; BIOPSY; ESOPHAGITIS; ESOPHAGUS; GASTROSCOPY; ISOLATION AND PURIFICATION; METAPLASIA; MICROBIOLOGY; PATHOLOGY; STOMACH MUCOSA;

BIOPSY; ESOPHAGITIS; ESOPHAGUS; GASTRIC MUCOSA; GASTROESOPHAGEAL REFLUX; GASTROSCOPY; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; METAPLASIA;

EID: 0037267371     PISSN: 09302794     EISSN: 14322218     Source Type: Journal    
DOI: 10.1007/s00464-002-8944-1     Document Type: Article

References (20)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JFJ (1991) Rising incidence of adenocarcinoma of the esophagus and gastric cardia [see Comments]. JAMA 265: 1287-1289
2. Blot WJ, McLaughlin JK (1999) The changing epidemiology of esophageal cancer. Semin Oncol 26 (Suppl 15): 2-8
3. Bowrey DJ, Clark GW, Williams GT (1999) Patterns of gastritis in patients with gastro-oesophageal reflux disease [see Comments]. Gut 45: 798-803
4. Chandrasoma P (2000) Re: Kilgore et al.: the gastric cardia: fact or fiction? Am J Gastroenterol 95: 2384
5. Chandrasoma P, Der R, Dalton P, Kobayashi G, Ma Y, JH P, DeMeester T (2001) Distribution and significance of epithelial cell types in columnar-lined esophagus. Am J Surg Pathol 25: 1188-1193
6. Couvelard A, Cauvin J-M, Goldfain D, Rotenberg A, Robaszkiewicz M, Flejou JF (2001) Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology. Gut 49: 761-766
7. DeMeester SR, Campos GM, DeMeester TR, Bremner CG, Hagen JA, Peters JH, Crookes PF (1998) The impact of an antireflux procedure on intestinal metaplasia of the cardia. Ann Surg 228: 547-556
8. Glickman JN, Wang H, Das KM, Goyal RK, Spechler SJ, Antonioli D, Odze RD (2001) Phenotype of Barrett's esophagus and intestinal metaplasia of the distal esophagus and gastroesophageal junction: an immunohistochemical study of cytokeratins 7 and 20, Das-1 and 45 MI. Am J Surg Pathol 25: 87-94
9. Goldblum J, Richter J, Vaezi MF, Falk GL, Rice TW, Peek RM (2002) Helicobacter pylori infection, not gastroesophageal reflux, is the major cause of inflammation and intestinal metaplasia of gastric cardiac mucosa. Am J Gastroenterol 97: 302-311
10. Goldblum JR, Vicari JJ, Falk GW, Rice TW, Peek RM, Easley K, Richter JE (1998) Inflammation and intestinal metaplasia of the gastric cardia: the role of gastroesophageal reflux and H. pylori infection [see Comments]. Gastroenterology 114: 633-639
11. Hackelsberger A, Gunther T, Schultze V, Manes G, Dominguez-Munoz JE, Roessner A, Malfertheiner P (1998) Intestinal metaplasia at the gastro-oesophageal junction: Helicobacter pylori gastritis or gastro-oesophageal reflux disease? Gut 43: 17-21
12. Morales TG, Sampliner RE, Bhattacharyya A (1997) Intestinal metaplasia of the gastric cardia. Am J Gasteroenterol 92: 414-418
13. Oberg S, Peters JH, DeMeester TR, Chandrasoma P, Hagen JA, Ireland AP, Ritter MP, Mason RJ, Crookes P, Bremner CG (1997) Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 226: 522-532
14. Ormsby AH, Goldblum JR, Rice TW, Richter JE, Falk GW, Vaezi MF, Gramlich TL (1999) Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Path 30: 288-294
15. Ormsby AH, Vaezi MF, Richter JE, Goldblum JR, Rice TW, Falk GW, Gramlich TL (2000) Cytokeratin immunoreactivity patterns in the diagnosis of short-segment Barrett's esophagus. Gastroenterology 119: 683-690
16. Paull A, Trier JS, Dalton MD, Camp RC, Loeb P, Goyal RK (1976) The histologic spectrum of Barrett's esophagus. New Eng J Med 295: 476-480
17. Spechler SJ, Zeroogian JM, Antonioli DA, Wang HH, Goyal RK (1994) Prevalence of metaplasia at the gastro-oesophageal junction. Lancet 344: 1533-1536
18. Sung J, Lin S, Ching I, Zhou L, To K, Wang R, Leung W, Ng E, Lau J, Lee Y, Yeung C, Chao W, Chung S (2000) Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 119: 7-14
19. Voutilainen M, Farkkila M, Juhola M, Nuorva K, Mauranen K, Mantynen T, Kunnamo I, Mecklin JP, Sipponen P (1999) Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study Group. Am J Gastroenterol 94: 913-918
20. DeMeester SR, Wickramasinghe K, Lord RV, Friedman A, Balaji P, Chandrasoma P, Hagen JA, Peters JH, DeMeester TR (2002) Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol 97 (in press)